SCHEDULE: Commodore Capital Reports 5.1% Stake in InflaRx

Commodore Capital LP, along with affiliated entities and individuals, has reported beneficial ownership of 7,475,000 ordinary shares, representing 5.1% of InflaRx N.V.

Summary

• Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz have jointly filed a Schedule 13G.
• This filing indicates beneficial ownership of 7,475,000 ordinary shares of InflaRx N.V.
• This holding represents 5.1% of the outstanding ordinary shares.
• The reporting date for this ownership stake is August 10, 2026.
• The shares were acquired and are held by Commodore Capital Master LP, with Commodore Capital LP acting as the investment manager.
• Michael Kramarz and Robert Egen Atkinson are managing partners of Commodore Capital LP and exercise investment discretion.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without new operational or financial disclosures.

Positives

• Significant institutional ownership established by Commodore Capital, indicating confidence in InflaRx's long-term prospects.
• The filing clearly delineates the ownership structure and responsible parties.

Negatives

• No new financial or operational information is provided, limiting insight into the rationale behind the investment.
• The filing does not disclose the acquisition cost or average purchase price of the shares.

Risks

• Potential for future share sales by Commodore Capital, which could impact InflaRx's stock price.
• Changes in investment strategy by Commodore Capital could lead to divestment.

Future Outlook

This filing does not contain forward-looking statements or guidance from InflaRx N.V. It solely reports on the beneficial ownership of securities by Commodore Capital entities.

Management Comments

• Commodore Capital LP may be deemed to beneficially own an aggregate of 7,475,000 ordinary shares.
• Michael Kramarz and Robert Egen Atkinson are the managing partners of the Firm and exercise investment discretion with respect to these securities.

Industry Context

StockSavvy.ai notes that significant stake acquisitions by investment firms like Commodore Capital often signal a belief in a company's growth potential or undervaluation within its sector, in this case, likely the biotechnology or pharmaceutical industry where InflaRx operates.

Stakeholder Impact

• Shareholders may view the increased institutional ownership positively, potentially leading to greater market interest.
• The market may interpret this acquisition as a sign of confidence, potentially influencing share price.

Next Steps

• Commodore Capital will continue to monitor its investment in InflaRx N.V.
• Future amendments to this Schedule 13G will be filed if beneficial ownership changes significantly.

Key Dates

Keywords

InflaRx N.V., Commodore Capital LP, Schedule 13G, Beneficial Ownership, Ordinary Shares, Investment Management, Institutional Investor